JAK2 V617F as a Marker for Long-Term Disease Progression and Mortality in Polycythemia Vera and its Role in Economic Modeling

BACKGROUND: In order to facilitate sound economic evaluations of novel treatments, health-economic models of polycythemia vera (PV) must combine effects on surrogate endpoints in trials with disease progression (DP) and mortality in long-term cohort data. OBJECTIVE: We validate an economic model for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hjelmgren, Jonas, Nilsson, Kristoffer, Birgegård, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2020
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343343/
https://www.ncbi.nlm.nih.gov/pubmed/32685599
http://dx.doi.org/10.36469/jheor.2020.13083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343343/
https://www.ncbi.nlm.nih.gov/pubmed/32685599
http://dx.doi.org/10.36469/jheor.2020.13083

Ejemplares similares